Drawing for MEDEVEX

USPTO serial 75891186

MEDEVEX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
FLETCHER, TRACY L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MEDEVEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Wise

MICHAEL J WISE LYON & LYON LLP633 W FIFTH ST STE 4700LOS ANGELES, CA 90071-2066UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Bioengineered and cadaverous tissues for medical and veterinary applications, namely transplantation, therapeutics, toxicity testing and pharmaceutical product development and substrates for growing bioengineered tissues, Pharmaceutical preparations for treatment of diseases and conditions, namely, ophthalmic, gastrointestinal, cardiovascular, respiratory, muscloskeletal, immunological, neurological, urogenital and dermatological diseases and conditions, Veterinary pharmaceutical preparations for dogs, cats, horses, livestock and birdsACTIVE
010Medical, surgical and veterinary devices and instruments for transplantation and therapeutics using bioengineered and cadaverous tissues; and for delivery of pharmaceuticalsACTIVE
035Computerized on-line distribution and retail store services via a Web site accessed by a global computer network featuring bioengineered and cadaverous tissues for medical and veterinary applications, namely transplantation, therapeutics, toxicity testing and pharmaceutical product development; substrates for growing bloengineered tissues; pharmaceutical preparations for treatment of diseases and conditions namely, ophthalmic, gastrointestinal, cardiovascular, respiratory, muscloskeletal, immunological, neurological, urogenital and dermatological diseases and conditions; veterinary pharmaceutical preparations for dogs, cats, horses, livestock and birds; medical, surgical and veterinary devices and instruments for transplantation and therapeutics using bioengineered and cadaverous tissues, and for delivery of pharmaceuticals and dental devices and solutions treatments of gingivitisACTIVE
042Computer services, namely, providing information via a Web site on a global computer network in the field of bioengineered and cadaverous tissues for medical and veterinary applications, namely transplantation, therapeutics, toxicity testing and pharmaceutical product development; substrates for growing bioengineered tissues; pharmaceutical preparations for treatment of diseases and conditions namely, ophthalmic, gastrointestinal, cardiovascular, respiratory, muscloskeletal, immunological, neurological, urogenital and dermatological diseases and conditions; veterinary pharmaceutical preparations for dogs, cats, horses, livestock and birds; medical, surgical and veterinary devices and instruments for transplantation and therapeutics using bioengineered and cadaverous tissues; and for delivery of pharmaceuticals and dental devices and solutions treatments of gingivitis3ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Mar 10, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 9, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 12, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance